Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00425750
Status:
COMPLETED
Last Update Posted:
2011-11-16
First Post:
2007-01-19
Brief Title:
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Vanderbilt-Ingram Cancer Center
Organization Data
Organization:
Vanderbilt-Ingram Cancer Center
Class:
OTHER
Study ID:
VICC HN 0501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Barbara Murphy
Responsible Party Title:
Professor of Medicine Director Cancer Supportive Care Program Director Head and Neck Research Program Medical Oncologist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Vanderbilt-Ingram Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |